Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID
Sponsor: Toivoa Inc
Trial Details
| Condition | Long Covid, Depression, Anxiety |
| Intervention | Rauha® Digital Therapeutic Platform (Toivoa-004) |
| Phase | NA |
| Status | Withdrawn |
| Participants | 20 |
| Est. Completion | 1 Sept 2026 |
| Last Updated | 29 July 2026 |
Primary Outcome
Proportion of active users at Week 12
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form. 2. Presence of clinically diagnosed Long COVID. 3. Stated willingness to comply with all study procedures and lifestyle considerations, and availability for the duration of the study. 4. Males and females; Age 22 and above. 5. Clinical Diagnosis of Long COVID 6. Willingness to adhere to the study regiment. 7. Access to necessary resources for participating in a technology-based intervention (i.e., Phone, internet access). 8. Able to read and speak English fluently. 9. Resident of the US and living in the US for the duration of the study. \_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Exclusion Criteria: 1. Self-reported substance use disorder. In the past 12 months (not including tobacco). 2. Self-reported suicide attempts in the past year or elevated suicide risk other than passive ideation (i.e., endorsing items reflecting intent, identifying means, suicide planning, or suicide-related preparations). 3. Currently pregnant or planning to become pregnant during the treatment period.
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service